LOINC_NUM,LONG_COMMON_NAME,TESTED
42176-8,"1,3 beta glucan [Mass/volume] in Serum",
53835-5,"1,5-Anhydroglucitol [Mass/volume] in Serum or Plasma",
31019-3,10-Hydroxycarbazepine [Mass/volume] in Serum or Plasma,
6765-2,17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma,
1668-3,17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma,
32854-2,17-Hydroxyprogesterone [Presence] in DBS,
49054-0,25-hydroxyvitamin D2 [Mass/volume] in Serum or Plasma,
1989-3,25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,
62292-8,25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma,
44907-4,5-Hydroxyindoleacetate panel - 24 hour Urine,
1690-7,5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma,
19593-3,6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method,
10976-9,6-Monoacetylmorphine (6-MAM) [Presence] in Urine,
51776-3,7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method,
882-1,ABO and Rh group [Type] in Blood,
46268-9,ABO and Rh group [Type] in Blood from Blood product unit--after transfusion reaction,
19057-9,ABO and Rh group [Type] in Blood from Newborn,
34530-6,ABO and Rh group panel - Blood,
883-9,ABO group [Type] in Blood,
3298-7,Acetaminophen [Mass/volume] in Serum or Plasma,
35595-8,Acetaminophen [Mass/volume] in Serum or Plasma by Screen method,
3297-9,Acetaminophen [Presence] in Serum or Plasma,
3299-5,Acetaminophen [Presence] in Urine,
5568-1,Acetone [Mass/volume] in Serum or Plasma,
20469-3,Acetone [Presence] in Serum or Plasma by Screen method,
5569-9,Acetone [Presence] in Urine,
20427-1,Acetylcholine receptor Ab [Moles/volume] in Serum,
11034-6,Acetylcholine receptor binding Ab [Moles/volume] in Serum,
11561-8,Acetylcholine receptor blocking Ab [Units/volume] in Serum,
30192-9,Acetylcholine receptor modulation Ab/Acetylcholine Ab.total in Serum,
6066-5,Acremonium sp IgE Ab [Units/volume] in Serum,
34661-9,Actin IgG Ab [Units/volume] in Serum or Plasma,
3184-9,Activated clotting time (ACT) of Blood by Coagulation assay,
48344-6,Activated clotting time.kaolin induced of Platelet poor plasma,
13589-7,Activated protein C resistance [Presence] in Blood by NAA with probe detection,
13590-5,Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay,
24363-4,Acute hepatitis 2000 panel - Serum,
45270-6,Acute leukemia panel - Specimen by Flow cytometry (FC),
1721-0,Adenosine triphosphate [Mass/volume] in Blood,
5834-7,Adenovirus Ag [Presence] in Specimen by Immunofluorescence,
55160-6,Adenovirus IgG and IgM panel - Serum,
1742-6,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,
1747-5,Albumin [Mass/volume] in Body fluid,
1746-7,Albumin [Mass/volume] in Cerebral spinal fluid,
1751-7,Albumin [Mass/volume] in Serum or Plasma,
1761-6,Aldolase [Enzymatic activity/volume] in Serum or Plasma,
1763-2,Aldosterone [Mass/volume] in Serum or Plasma,
55151-5,Aldosterone and renin activity panel - Plasma,
6768-6,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,"FOSFATASA ALCALINA, U/L"
1777-2,Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma,
17838-4,Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma,
6019-4,Almond IgE Ab [Units/volume] in Serum,
1825-9,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma,
6771-0,Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry,
1823-4,Alpha tocopherol [Mass/volume] in Serum or Plasma,
1834-1,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,
19171-8,Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid,
10459-6,Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain,
48802-3,Alpha-1-Fetoprotein panel - Serum or Plasma,
53962-7,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,
6020-2,Alternaria alternata IgE Ab [Units/volume] in Serum,
5574-9,Aluminum [Mass/volume] in Serum or Plasma,
6038-4,American Beech IgE Ab [Units/volume] in Serum,
30170-5,American Cockroach IgE Ab [Units/volume] in Serum,
6095-4,American house dust mite IgE Ab [Units/volume] in Serum,
6263-8,American Sycamore IgE Ab [Units/volume] in Serum,
3321-7,Amikacin [Mass/volume] in Serum or Plasma --trough,
35083-5,Amino acids panel [Moles/volume] - Serum or Plasma,
55152-3,Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma,
22763-7,Ammonia [Mass/volume] in Plasma,
16362-6,Ammonia [Moles/volume] in Plasma,
19343-3,Amphetamine [Presence] in Urine by Screen method,
8150-5,Amphetamines [Mass/volume] in Urine,
8144-8,Amphetamines [Presence] in Meconium,
8146-3,Amphetamines [Presence] in Meconium by Screen method,
8149-7,Amphetamines [Presence] in Serum or Plasma by Screen method,
3349-8,Amphetamines [Presence] in Urine,
19261-7,Amphetamines [Presence] in Urine by Screen method,
43983-6,Amphetamines [Presence] in Urine by Screen method >500 ng/mL,
1795-4,Amylase [Enzymatic activity/volume] in Body fluid,
1798-8,Amylase [Enzymatic activity/volume] in Serum or Plasma,
33915-0,Anabasine [Mass/volume] in Urine,
23877-4,Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence,
23878-2,Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence,
1848-1,Androstanolone [Mass/volume] in Serum or Plasma,
1854-9,Androstenedione [Mass/volume] in Serum or Plasma,
1857-2,Angiotensin converting enzyme [Enzymatic activity/volume] in Blood,
12480-0,Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid,
2742-5,Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma,
3174-0,Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic method,
27811-9,Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,
3175-7,Antithrombin Ag [Units/volume] in Platelet poor plasma by Immunoassay,
27812-7,Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay,
21619-2,APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
1869-7,Apolipoprotein A-I [Mass/volume] in Serum or Plasma,
55724-9,Apolipoprotein A-I and A-II and B and C panel [Mass/volume] - Serum or Plasma,
1884-6,Apolipoprotein B [Mass/volume] in Serum or Plasma,
1871-3,Apolipoprotein B-100 [Mass/volume] in Serum or Plasma,
1881-2,Apolipoprotein LPA [Mass/volume] in Serum or Plasma,
6021-0,Apple IgE Ab [Units/volume] in Serum,
3173-2,aPTT in Blood by Coagulation assay,
49058-1,aPTT in Blood drawn from CRRT circuit by Coagulation assay,
14979-9,aPTT in Platelet poor plasma by Coagulation assay,
3282-1,aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assay,
61430-5,Aquaporin 4 water channel Ab [Units/volume] in Serum or Plasma by Immunoassay,
5583-0,Arsenic [Mass/volume] in Blood,
54454-4,Arsenic fractions panel - Urine,
1903-4,Ascorbate [Mass/volume] in Serum or Plasma,
14622-5,Ascorbate [Moles/volume] in Serum or Plasma,
1920-8,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,
9490-4,Aspergillus flavus Ab [Presence] in Serum,
9632-1,Aspergillus fumigatus Ab [Presence] in Serum,
6025-1,Aspergillus fumigatus IgE Ab [Units/volume] in Serum,
22086-3,Aspergillus niger Ab [Presence] in Serum,
5052-6,Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID),
5053-4,Aspergillus sp Ab [Titer] in Serum by Complement fixation,
6029-3,Aureobasidium pullulans IgE Ab [Units/volume] in Serum,
16117-4,Babesia microti IgG Ab [Titer] in Serum,
16118-2,Babesia microti IgM Ab [Titer] in Serum,
44023-0,Bacteria [Presence] in Vaginal fluid by Wet preparation,
595-9,Bacteria identified in Abscess by Aerobe culture,
600-7,Bacteria identified in Blood by Culture,
610-6,Bacteria identified in Body fluid by Aerobe culture,
611-4,Bacteria identified in Body fluid by Culture,
19126-2,Bacteria identified in Bone marrow by Aerobe culture,
43441-5,Bacteria identified in Bronchoalveolar lavage by Aerobe culture,
19128-8,Bacteria identified in Catheter tip by Culture,
606-4,Bacteria identified in Cerebral spinal fluid by Culture,
9822-8,Bacteria identified in Dialysis fluid by Culture,
608-0,Bacteria identified in Ear by Aerobe culture,
609-8,Bacteria identified in Eye by Aerobe culture,
10352-3,Bacteria identified in Genital specimen by Aerobe culture,
42803-7,Bacteria identified in Isolate,
10353-1,Bacteria identified in Nose by Aerobe culture,
619-7,Bacteria identified in Peritoneal fluid by Culture,
634-6,Bacteria identified in Specimen by Aerobe culture,
635-3,Bacteria identified in Specimen by Anaerobe culture,
21020-3,Bacteria identified in Specimen by Anaerobe+Aerobe culture,
6463-4,Bacteria identified in Specimen by Culture,
32355-0,Bacteria identified in Specimen by Respiratory culture,
6460-0,Bacteria identified in Sputum by Culture,
623-9,Bacteria identified in Sputum by Cystic fibrosis respiratory culture,
624-7,Bacteria identified in Sputum by Respiratory culture,
625-4,Bacteria identified in Stool by Culture,
621-3,Bacteria identified in Synovial fluid by Culture,
17898-8,Bacteria identified in Throat by Aerobe culture,
626-2,Bacteria identified in Throat by Culture,
627-0,Bacteria identified in Tissue by Aerobe culture,
20474-3,Bacteria identified in Tissue by Biopsy culture,
630-4,Bacteria identified in Urine by Culture,
11261-5,Bacteria identified in Vaginal fluid by Aerobe culture,
6462-6,Bacteria identified in Wound by Culture,
43407-6,Bacteria identified in Wound deep by Culture,
41477-1,Bacterial sialidase [Presence] in Specimen,
54145-8,Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe with signal amplification,
6034-3,Bahia grass IgE Ab [Units/volume] in Serum,
31032-6,Baker's yeast IgA Ab [Units/volume] in Serum,
47320-7,Baker's yeast IgA Ab [Units/volume] in Serum by Immunoassay,
6287-7,Baker's yeast IgE Ab [Units/volume] in Serum,
35538-8,Baker's yeast IgG Ab [Mass/volume] in Serum,
6035-0,Banana IgE Ab [Units/volume] in Serum,
9426-8,Barbiturates [Mass/volume] in Urine,
3376-1,"Barbiturates [Presence] in Serum, Plasma or Blood",
3377-9,Barbiturates [Presence] in Urine,
19270-8,Barbiturates [Presence] in Urine by Screen method,
6037-6,Barley IgE Ab [Units/volume] in Serum,
9360-9,Bartonella quintana IgG Ab [Titer] in Serum,
9361-7,Bartonella quintana IgM Ab [Titer] in Serum,
24321-2,Basic metabolic 2000 panel - Serum or Plasma,
7124-1,Bayberry Pollen IgE Ab [Units/volume] in Serum,
6039-2,Beef IgE Ab [Units/volume] in Serum,
9428-4,Benzodiazepines [Mass/volume] in Urine,
3389-4,Benzodiazepines [Presence] in Serum or Plasma,
3390-2,Benzodiazepines [Presence] in Urine,
16195-0,Benzodiazepines [Presence] in Urine by Confirmatory method,
14316-4,Benzodiazepines [Presence] in Urine by Screen method,
70141-7,Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL,
8187-7,Benzoylecgonine [Presence] in Meconium,
3393-6,Benzoylecgonine [Presence] in Urine,
14314-9,Benzoylecgonine [Presence] in Urine by Screen method,
43984-4,Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL,
6041-8,Bermuda grass IgE Ab [Units/volume] in Serum,
21108-6,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum,
44447-1,Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay,
16135-6,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum,
44448-9,Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,
72488-0,Beta 2 glycoprotein 1 IgG and IgM panel - Serum,
16136-4,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum,
44449-7,Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,
29512-1,Beta hydroxybutyrate [Mass/volume] in Serum or Plasma,
6873-4,Beta hydroxybutyrate [Moles/volume] in Serum or Plasma,
20423-0,Beta lactamase organism identified in Isolate,
1952-1,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,
14628-2,Bile acid [Moles/volume] in Serum or Plasma,
43130-4,Bile acid fractions panel [Moles/volume] - Serum or Plasma,
34543-9,Bilirubin direct and total panel [Mass/volume] - Serum or Plasma,
1968-7,Bilirubin.direct [Mass/volume] in Serum or Plasma,Bilirrubina no conjugada
1974-5,Bilirubin.total [Mass/volume] in Body fluid,
1975-2,Bilirubin.total [Mass/volume] in Serum or Plasma,
1978-6,Bilirubin.total [Mass/volume] in Urine,
1977-8,Bilirubin.total [Presence] in Urine,
38478-4,Biotinidase [Presence] in DBS,
41479-7,BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,
41480-5,BK virus DNA [#/volume] (viral load) in Urine by NAA with probe detection,
32284-2,BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,
7816-2,Blastomyces dermatitidis Ab [Presence] in Serum,
5057-5,Blastomyces dermatitidis Ab [Titer] in Serum by Complement fixation,
6313-1,Blastomyces dermatitidis Ag [Presence] in Serum by Immunoassay,
11067-6,Bleeding time,
33720-4,Blood bank consult,
888-8,Blood group antibodies identified in Serum or Plasma,
14575-5,Blood group antibody investigation [Interpretation] in Plasma or RBC,
890-4,Blood group antibody screen [Presence] in Serum or Plasma,
34532-2,Blood type and Indirect antibody screen panel - Blood,
33721-2,Bone marrow Pathology biopsy report,
48741-3,Bordetella pertussis [Presence] in Nasopharynx by Organism specific culture,
43381-3,Bordetella pertussis Ab [Presence] in Specimen by Immunofluorescence,
550-4,Bordetella pertussis Ag [Presence] in Specimen by Immunofluorescence,
42330-1,Bordetella pertussis IgG Ab [Units/volume] in Serum by Immunoassay,
11006-4,Borrelia burgdorferi Ab [Presence] in Serum,
20449-5,Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay,
6318-0,Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid by Immunoassay,
4991-6,Borrelia burgdorferi DNA [Presence] in Specimen by NAA with probe detection,
7817-0,Borrelia burgdorferi IgG Ab [Units/volume] in Serum,
5062-5,Borrelia burgdorferi IgG Ab [Units/volume] in Serum by Immunoassay,
22131-7,Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum,
34148-7,Borrelia burgdorferi IgG+IgM Ab [Units/volume] in Serum,
62341-3,Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum,
5064-1,Borrelia burgdorferi IgM Ab [Units/volume] in Serum by Immunoassay,
7155-5,Boxelder IgE Ab [Units/volume] in Serum,
38479-2,Branched chain keto-acid dehydrogenase complex [Presence] in DBS,
6050-9,Brazil Nut IgE Ab [Units/volume] in Serum,
3414-0,Buprenorphine [Presence] in Urine,
1986-9,C peptide [Mass/volume] in Serum or Plasma,
1988-5,C reactive protein [Mass/volume] in Serum or Plasma,
30522-7,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,
11039-5,C reactive protein [Presence] in Serum or Plasma,
5609-3,Cadmium [Mass/volume] in Blood,
3422-3,Caffeine [Mass/volume] in Serum or Plasma,
49590-3,Calcidiol and Calciferol panel - Serum or Plasma,
2236-8,Calciferol (Vit D2) [Mass/volume] in Serum or Plasma,
1992-7,Calcitonin [Mass/volume] in Serum or Plasma,
1649-3,Calcitriol [Mass/volume] in Serum or Plasma,
18488-7,Calcium [Mass/volume] in 24 hour Urine,
49765-1,Calcium [Mass/volume] in Blood,
17861-6,Calcium [Mass/volume] in Serum or Plasma,
17862-4,Calcium [Mass/volume] in Urine,
35675-8,Calcium [Mass/volume] in Urine collected for unspecified duration,
38230-9,Calcium.ionized [Mass/volume] in Blood,
17863-2,Calcium.ionized [Mass/volume] in Serum or Plasma,
17864-0,Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE),
1994-3,Calcium.ionized [Moles/volume] in Blood,
1995-0,Calcium.ionized [Moles/volume] in Serum or Plasma,
49255-3,Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy,
6274-5,California Walnut IgE Ab [Units/volume] in Serum,
38445-3,Calprotectin [Mass/mass] in Stool,
6331-3,Campylobacter sp identified in Stool by Organism specific culture,
2006-5,Cancer Ag 125 [Presence] in Serum or Plasma,
10334-1,Cancer Ag 125 [Units/volume] in Serum or Plasma,
6875-9,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,
24108-3,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,
17842-6,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,
6059-0,Candida albicans IgE Ab [Units/volume] in Serum,
35270-8,Candida sp Ab [Presence] in Serum by Immune diffusion (ID),
47000-5,Candida sp rRNA [Presence] in Vaginal fluid by Probe,
42860-7,Cannabinoids [Mass/volume] in Urine,
31080-5,Cannabinoids [Presence] in Meconium by Screen method,
18282-4,Cannabinoids [Presence] in Urine by Screen method,
70145-8,Cannabinoids [Presence] in Urine by Screen method >50 ng/mL,
3432-2,carBAMazepine [Mass/volume] in Serum or Plasma,
2028-9,"Carbon dioxide, total [Moles/volume] in Serum or Plasma",
3436-3,Carboxy tetrahydrocannabinol [Mass/volume] in Urine,
20521-1,Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method,
20563-3,Carboxyhemoglobin/Hemoglobin.total in Blood,
2039-6,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,
5076-5,Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay,
45057-7,Cardiolipin IgA and IgG and IgM panel - Serum,
3181-5,Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay,
24319-6,Cardiolipin IgG and IgM panel - Serum,
3182-3,Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay,
2053-7,Carotene [Mass/volume] in Serum or Plasma,
6061-6,Carrot IgE Ab [Units/volume] in Serum,
6062-4,Casein IgE Ab [Units/volume] in Serum,
53829-8,Casein IgG Ab [Mass/volume] in Serum,
6718-1,Cashew nut IgE Ab [Units/volume] in Serum,
6833-8,Cat dander IgE Ab [Units/volume] in Serum,
73879-9,Catecholamine metabolites and creatinine panel - Urine,
58410-2,CBC panel - Blood by Automated count,
57021-8,CBC W Auto Differential panel - Blood,
69742-5,"CBC W Differential panel, method unspecified - Blood",
57782-5,CBC W Ordered Manual Differential panel - Blood,
57022-6,CBC W Reflex Manual Differential panel - Blood,
34557-9,Cell count and Differential panel - Body fluid,
34564-5,Cell count and Differential panel - Cerebral spinal fluid,
34556-1,Cell count panel - Body fluid,
34563-7,Cell count panel - Cerebral spinal fluid,
8068-9,Centromere Ab [Units/volume] in Serum,
53982-5,Centromere protein B Ab [Units/volume] in Serum,
2064-4,Ceruloplasmin [Mass/volume] in Serum or Plasma,
21654-9,CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
38404-0,CFTR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,
19734-3,Chicken droppings IgE Ab [Units/volume] in Serum,
6070-7,Chicken feather IgE Ab [Units/volume] in Serum,
6071-5,Chicken meat IgE Ab [Units/volume] in Serum,
560-3,Chlamydia sp identified in Specimen by Organism specific culture,
6349-5,Chlamydia trachomatis [Presence] in Specimen by Organism specific culture,
36903-3,Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection,
64017-7,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Specimen by NAA with probe detection,
21190-4,Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection,
21613-5,Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection,
6357-8,Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection,
50387-0,Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection,
43304-5,Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection,
4993-2,Chlamydia trachomatis rRNA [Presence] in Specimen by Probe,
53925-4,Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection,
42931-6,Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection,
21184-7,Chlamydophila pneumoniae [Presence] in Specimen by Organism specific culture,
2069-3,Chloride [Moles/volume] in Blood,
2075-0,Chloride [Moles/volume] in Serum or Plasma,
2077-6,Chloride [Moles/volume] in Sweat,
2078-4,Chloride [Moles/volume] in Urine,
35676-6,Chloride [Moles/volume] in Urine collected for unspecified duration,
6073-1,Chocolate IgE Ab [Units/volume] in Serum,
1990-1,Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma,
2093-3,Cholesterol [Mass/volume] in Serum or Plasma,
2085-9,Cholesterol in HDL [Mass/volume] in Serum or Plasma,
2089-1,Cholesterol in LDL [Mass/volume] in Serum or Plasma,
18262-6,Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay,
35558-6,Cholinesterase panel [Enzymatic activity/volume] - Blood,
2118-8,Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma,
2106-3,Choriogonadotropin (pregnancy test) [Presence] in Urine,
19080-1,Choriogonadotropin [Units/volume] in Serum or Plasma,
25372-4,Choriogonadotropin [Units/volume] in Urine,
2110-5,Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma,
2112-1,Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine,
2111-3,Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma,
2114-7,Choriogonadotropin.beta subunit [Moles/volume] in Urine,
43799-6,Choriogonadotropin.beta subunit [Presence] in Specimen,
21198-7,Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma,
2115-4,Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma,
30243-0,Choriogonadotropin.intact [Units/volume] in Serum or Plasma,
45194-8,Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma,
53959-3,Choriogonadotropin.tumor marker [Units/volume] in Serum or Plasma,
51775-5,Chromatin Ab [Units/volume] in Serum or Plasma,
5619-2,Chromium [Mass/volume] in Blood,
5622-6,Chromium [Mass/volume] in Serum or Plasma,
9811-1,Chromogranin A [Mass/volume] in Serum or Plasma,
25587-7,Chromogranin A [Moles/volume] in Serum or Plasma,
30169-7,Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay,
50659-2,Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative,
45269-8,Chronic leukemia panel - Specimen by Flow cytometry (FC),
20640-9,Citrulline [Moles/volume] in Serum or Plasma,
6075-6,Cladosporium herbarum IgE Ab [Units/volume] in Serum,
7415-3,Cladosporium sphaerospermum IgE Ab [Units/volume] in Serum,
6076-4,Clam IgE Ab [Units/volume] in Serum,
35603-0,clonazePAM [Mass/volume] in Serum or Plasma by Screen method,
34712-0,Clostridioides difficile [Presence] in Stool,
20761-3,Clostridioides difficile [Presence] in Stool by Agglutination,
61367-9,Clostridioides difficile DNA [Presence] in Specimen by NAA with probe detection,
34713-8,Clostridioides difficile toxin A+B [Presence] in Stool,
6362-8,Clostridioides difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay,
34468-9,Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,
54067-4,Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection,
22203-4,Clostridium tetani IgG Ab [Units/volume] in Serum,
6367-7,Clostridium tetani IgG Ab [Units/volume] in Serum by Immunoassay,
6896-5,cloZAPine [Mass/volume] in Serum or Plasma,
65632-2,cloZAPine and Norclozapine panel - Serum or Plasma,
3187-2,Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay,
3193-0,Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay,
3198-9,Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay,
3209-4,Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay,
3218-5,Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay,
3226-8,Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay,
16695-9,Cobalamin (Vitamin B12) [Mass/volume] in Blood,
2132-9,Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,
5625-9,Cobalt [Mass/volume] in Blood,
5627-5,Cobalt [Mass/volume] in Serum or Plasma,
40527-4,Cocaine [Presence] in Meconium,
8191-9,Cocaine [Presence] in Serum or Plasma by Screen method,
3397-7,Cocaine [Presence] in Urine,
53743-1,Cocaine metabolites.other [Mass/volume] in Urine,
5095-5,Coccidioides immitis Ab [Presence] in Serum by Immune diffusion (ID),
5096-3,Coccidioides immitis Ab [Titer] in Serum by Complement fixation,
13947-7,Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay,
13948-5,Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay,
6078-0,Cockroach IgE Ab [Units/volume] in Serum,
24139-8,Cockroach IgG Ab [Units/volume] in Serum,
6195-2,Cocksfoot IgE Ab [Units/volume] in Serum,
6081-4,Coconut IgE Ab [Units/volume] in Serum,
16250-3,Codeine [Mass/volume] in Urine by Confirmatory method,
3507-1,Codeine [Presence] in Urine,
6082-2,Codfish IgE Ab [Units/volume] in Serum,
27923-2,Coenzyme Q10 [Mass/volume] in Serum or Plasma,
5098-9,Cold agglutinin [Titer] in Serum or Plasma by Agglutination,
41171-0,Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma,
21215-9,Collagen crosslinked N-telopeptide [Moles/volume] in Serum,
27939-8,Collagen crosslinked N-telopeptide [Moles/volume] in Urine,
14115-0,Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine,
7604-2,Common Pigweed IgE Ab [Units/volume] in Serum,
6085-5,Common Ragweed IgE Ab [Units/volume] in Serum,
4477-6,Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma,
10634-4,Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma,
4485-9,Complement C3 [Mass/volume] in Serum or Plasma,
34544-7,Complement C3 and C4 panel [Mass/volume] - Serum or Plasma,
4498-2,Complement C4 [Mass/volume] in Serum or Plasma,
4532-8,Complement total hemolytic CH50 [Units/volume] in Serum or Plasma,
24323-8,Comprehensive metabolic 2000 panel - Serum or Plasma,
5631-7,Copper [Mass/volume] in Serum or Plasma,
51662-5,Core respiratory allergens panel - Serum,
6087-1,Corn IgE Ab [Units/volume] in Serum,
2141-0,Corticotropin [Mass/volume] in Plasma,
2142-8,Cortisol [Mass/volume] in Saliva (oral fluid),
2143-6,Cortisol [Mass/volume] in Serum or Plasma,
9813-7,Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen,
9812-9,Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen,
2147-7,Cortisol Free [Mass/time] in 24 hour Urine,
2145-1,Cortisol Free [Mass/volume] in Serum or Plasma,
11040-3,Cortisol Free [Mass/volume] in Urine,
5116-9,Corynebacterium diphtheriae Ab [Units/volume] in Serum by Immunoassay,
13227-4,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum,
58787-3,Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum by Immunoassay,
10366-3,Cotinine [Mass/volume] in Urine,
12293-7,Cotinine [Presence] in Urine,
6090-5,Cottonwood IgE Ab [Units/volume] in Serum,
7258-7,Cow milk IgE Ab [Units/volume] in Serum,
56234-8,Cow milk IgG4 Ab [Mass/volume] in Serum,
7774-3,Cow whey IgE Ab [Units/volume] in Serum,
41840-0,Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum,
41484-7,Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation,
41485-4,Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation,
6092-1,Crab IgE Ab [Units/volume] in Serum,
2157-6,Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,
32673-6,Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma,
49551-5,Creatine kinase.MB [Mass/volume] in Blood,
13969-1,Creatine kinase.MB [Mass/volume] in Serum or Plasma,
20624-3,Creatinine [Mass/volume] in 24 hour Urine,
2159-2,Creatinine [Mass/volume] in Amniotic fluid,
38483-4,Creatinine [Mass/volume] in Blood,
12190-5,Creatinine [Mass/volume] in Body fluid,
2160-0,Creatinine [Mass/volume] in Serum or Plasma,
2161-8,Creatinine [Mass/volume] in Urine,
35674-1,Creatinine [Mass/volume] in Urine collected for unspecified duration,
65634-8,Creatinine 24 hour urine panel - 24 hour Urine,
58446-6,Creatinine 24H renal clearance adjusted for body surface area panel,
34555-3,Creatinine 24H renal clearance panel,
45066-8,"Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood",
11043-7,Cryofibrinogen [Presence] in Plasma,
5117-7,Cryoglobulin [Presence] in Serum,
31788-3,Cryptococcus sp Ag [Presence] in Cerebral spinal fluid,
29533-7,Cryptococcus sp Ag [Presence] in Specimen,
9820-2,Cryptococcus sp Ag [Titer] in Serum by Latex agglutination,
41487-0,Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay,
20781-1,Cryptosporidium sp [Presence] in Stool by Acid fast stain,
6371-9,Cryptosporidium sp Ag [Presence] in Stool by Immunoassay,
6372-7,Cryptosporidium sp Ag [Titer] in Stool by Immunofluorescence,
6825-4,Crystals [type] in Body fluid by Light microscopy,
5781-0,Crystals [type] in Synovial fluid by Light microscopy,
32218-0,Cyclic citrullinated peptide Ab [Units/volume] in Serum by Immunoassay,
57093-7,Cyclic citrullinated peptide IgA+IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,
33935-8,Cyclic citrullinated peptide IgG Ab [Units/volume] in Serum or Plasma,
3520-4,cycloSPORINE [Mass/volume] in Blood,
32997-9,cycloSPORINE [Mass/volume] in Blood --2 hours post dose,
33863-2,Cystatin C [Mass/volume] in Serum or Plasma,
54078-1,Cystic fibrosis newborn screening panel,
47528-5,Cytology report of Cervical or vaginal smear or scraping Cyto stain,
47527-7,Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep,
33718-8,Cytology report of Tissue fine needle aspirate Cyto stain,
5838-8,Cytomegalovirus [Presence] in Specimen by Organism specific culture,
31797-4,Cytomegalovirus Ag [Presence] in Specimen,
6379-2,Cytomegalovirus Ag [Presence] in Specimen by Immunoassay,
30247-1,Cytomegalovirus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,
33006-8,Cytomegalovirus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,
28008-1,Cytomegalovirus DNA [Presence] in Blood by Probe with signal amplification,
30246-3,Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection,
5000-5,Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection,
7852-7,Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma,
5124-3,Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,
24315-4,Cytomegalovirus IgG and IgM panel - Serum or Plasma,
24119-0,Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay,
49539-0,Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence,
5127-6,Cytomegalovirus IgM Ab [Titer] in Serum or Plasma by Immunofluorescence,
5126-8,Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,
2193-1,Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma,
2196-4,Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma,
2191-5,Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma,
41878-0,Dengue virus IgG and IgM panel - Serum by Immunoassay,
10535-3,Digoxin [Mass/volume] in Serum or Plasma,
1007-4,Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells,
11013-0,DNA double strand Ab [Titer] in Serum,
34187-5,DNA double strand Ab [Titer] in Serum by Immunofluorescence (IF) Crithidia luciliae,
5130-0,DNA double strand Ab [Units/volume] in Serum,
10360-6,DNA single strand IgG Ab [Units/volume] in Serum,
6098-8,Dog dander IgE Ab [Units/volume] in Serum,
6099-6,Dog epithelium IgE Ab [Units/volume] in Serum,
7287-6,Dog Fennel IgE Ab [Units/volume] in Serum,
2218-6,DOPamine [Mass/time] in 24 hour Urine,
2216-0,DOPamine [Mass/volume] in Serum or Plasma,
2217-8,DOPamine [Mass/volume] in Urine,
40464-0,Drugs identified in Urine by Confirmatory method,
65750-2,Drugs of abuse 5 panel - Urine by Screen method,
6303-2,dRVVT (LA screen),
6282-8,Eastern White Pine IgE Ab [Units/volume] in Serum,
21665-5,EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
6106-9,Egg white IgE Ab [Units/volume] in Serum,
6107-7,Egg yolk IgE Ab [Units/volume] in Serum,
9783-2,Ehrlichia chaffeensis IgG Ab [Titer] in Serum,
45059-3,Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence,
9784-0,Ehrlichia chaffeensis IgM Ab [Titer] in Serum,
25907-7,Elastase.pancreatic [Mass/mass] in Stool,
24326-1,Electrolytes 1998 panel - Serum or Plasma,
55231-5,Electrolytes panel - Blood,
14708-2,Endomysium Ab [Titer] in Serum,
10362-2,Endomysium IgA Ab [Presence] in Serum,
10863-9,Endomysium IgA Ab [Titer] in Serum,
27038-9,Endomysium IgA Ab [Titer] in Serum by Immunofluorescence,
20797-7,Endotoxin identified in Specimen,
6110-1,English plantain IgE Ab [Units/volume] in Serum,
15060-7,Enolase.neuron specific [Mass/volume] in Serum or Plasma,
9522-4,Entamoeba histolytica IgG Ab [Units/volume] in Serum by Immunoassay,
675-9,Enterobius vermicularis [Presence] in Specimen by Pinworm exam,
29591-5,Enterovirus RNA [Presence] in Specimen by NAA with probe detection,
26449-9,Eosinophils [#/volume] in Blood,
711-2,Eosinophils [#/volume] in Blood by Automated count,
48049-1,Eosinophils [Presence] in Stool by Wright stain,
49839-4,Eosinophils [Presence] in Urine sediment by Wright stain,
12210-1,Eosinophils/100 leukocytes in Urine sediment by Manual count,
30339-6,Epstein Barr virus capsid IgG Ab [Presence] in Serum,
24114-1,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay,
40750-2,Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunofluorescence,
5158-1,Epstein Barr virus capsid IgG Ab [Titer] in Serum by Immunofluorescence,
7885-7,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum,
5157-3,Epstein Barr virus capsid IgG Ab [Units/volume] in Serum by Immunoassay,
24316-2,Epstein Barr virus capsid IgG and IgM panel - Serum,
30340-4,Epstein Barr virus capsid IgM Ab [Presence] in Serum,
24115-8,Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay,
5160-7,Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence,
7886-5,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum,
5159-9,Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay,
32585-2,Epstein Barr virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,
5005-4,Epstein Barr virus DNA [Presence] in Specimen by NAA with probe detection,
14083-0,Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence,
40752-8,Epstein Barr virus early IgG Ab [Presence] in Serum by Immunoassay,
24007-7,Epstein Barr virus early IgG Ab [Units/volume] in Serum,
56598-6,Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay,
22296-8,Epstein Barr virus nuclear Ab [Presence] in Serum,
22297-6,Epstein Barr virus nuclear Ab [Titer] in Serum,
21260-5,Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence,
7883-2,Epstein Barr virus nuclear IgG Ab [Presence] in Serum,
5156-5,Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay,
31374-2,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum,
30083-0,Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum by Immunoassay,
30341-2,Erythrocyte sedimentation rate,
4537-7,Erythrocyte sedimentation rate by Westergren method,
789-8,Erythrocytes [#/volume] in Blood by Automated count,
15061-5,Erythropoietin (EPO) [Units/volume] in Serum or Plasma,
21262-1,Escherichia coli shiga-like toxin [Presence] in Stool by Immunoassay,
2243-4,Estradiol (E2) [Mass/volume] in Serum or Plasma,
35384-7,Estradiol (E2) [Mass/volume] in Serum or Plasma by High sensitivity method,
2251-7,Estriol (E3) [Mass/volume] in Serum or Plasma,
2250-9,Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma,
2254-1,Estrogen [Mass/volume] in Serum or Plasma,
53766-2,Estrogen fraction panel - Serum or Plasma,
2258-2,Estrone (E1) [Mass/volume] in Serum or Plasma,
5640-8,Ethanol [Mass/volume] in Blood,
5643-2,Ethanol [Mass/volume] in Serum or Plasma,
5645-7,Ethanol [Mass/volume] in Urine,
5639-0,Ethanol [Presence] in Blood,
5644-0,Ethanol [Presence] in Urine,
3616-0,Ethosuximide [Mass/volume] in Serum or Plasma,
45324-1,Ethyl glucuronide [Mass/volume] in Urine,
58375-7,Ethyl glucuronide [Presence] in Urine by Screen method,
5646-5,"Ethylene glycol [Mass/volume] in Serum, Plasma or Blood",
6096-2,European house dust mite IgE Ab [Units/volume] in Serum,
50544-6,Everolimus [Mass/volume] in Blood,
24475-6,F2 gene c.20210G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal,
24476-4,F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
21667-1,F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
1558-6,Fasting glucose [Mass/volume] in Serum or Plasma,
16142-2,Fat [Mass/time] in 24 hour Stool,
2270-7,Fat [Presence] in Stool,
12598-9,Fat.neutral [Presence] in Stool,
11235-9,fentaNYL [Presence] in Urine,
2276-4,Ferritin [Mass/volume] in Serum or Plasma,
29280-5,Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutination,
48066-5,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma,
48058-2,Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasma by Immunoassay,
48065-7,Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma,
3255-7,Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,
3256-5,Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay,
48039-2,Fibronectin.fetal [Presence] in Specimen,
20404-0,Fibronectin.fetal [Presence] in Vaginal fluid,
48798-3,First trimester maternal screen panel - Serum or Plasma,
33719-6,Flow cytometry study,
21759-6,FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method,
36913-2,FMR1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,
2282-2,Folate [Mass/volume] in Blood,
2283-0,Folate [Mass/volume] in Red Blood Cells,
2284-8,Folate [Mass/volume] in Serum or Plasma,
15067-2,Follitropin [Units/volume] in Serum or Plasma,
34549-6,Follitropin and Lutropin panel [Units/volume] - Serum or Plasma,
15218-1,Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk,
49222-3,Food allergen panel - Serum,
21760-4,FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method,
721-1,Free Hemoglobin [Mass/volume] in Plasma,
4635-9,Free Hemoglobin [Mass/volume] in Serum,
15069-8,Fructosamine [Moles/volume] in Serum or Plasma,
13943-6,Fructose [Presence] in Semen,
56146-4,Fungal Ab panel - Serum,
601-5,Fungus identified in Blood by Culture,
15378-3,Fungus identified in Isolate by Culture,
575-1,Fungus identified in Skin by Culture,
580-1,Fungus identified in Specimen by Culture,
21003-9,Fungus identified in Specimen by Fungus stain,
6121-8,Fusarium moniliforme IgE Ab [Units/volume] in Serum,
9738-6,"Gabapentin [Mass/volume] in Serum, Plasma or Blood",
44099-0,Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay,
35383-9,Galactomannan Ag [Units/volume] in Serum or Plasma,
44357-2,Galactomannan Ag [Units/volume] in Serum or Plasma by Immunoassay,
62419-7,Galectin 3 [Mass/volume] in Serum or Plasma,
2324-2,Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,
6410-5,Gardnerella vaginalis rRNA [Presence] in Genital specimen by Probe,
2333-3,Gastrin [Mass/volume] in Serum or Plasma,
35668-3,Gentamicin [Mass/volume] in Serum or Plasma,
3663-2,Gentamicin [Mass/volume] in Serum or Plasma --peak,
3665-7,Gentamicin [Mass/volume] in Serum or Plasma --trough,
6412-1,Giardia lamblia Ag [Presence] in Stool by Immunoassay,
48060-8,Giardia lamblia+Cryptosporidium sp Ag [Presence] in Stool,
7893-1,Gliadin Ab [Units/volume] in Serum,
6924-5,Gliadin IgA Ab [Units/volume] in Serum,
20495-8,Gliadin IgA Ab [Units/volume] in Serum by Immunoassay,
5170-6,Gliadin IgG Ab [Units/volume] in Serum,
20496-6,Gliadin IgG Ab [Units/volume] in Serum by Immunoassay,
30343-8,Glomerular basement membrane IgG Ab [Units/volume] in Serum by Immunoassay,
2339-0,Glucose [Mass/volume] in Blood,
2344-0,Glucose [Mass/volume] in Body fluid,
32016-8,Glucose [Mass/volume] in Capillary blood,
41653-7,Glucose [Mass/volume] in Capillary blood by Glucometer,
2342-4,Glucose [Mass/volume] in Cerebral spinal fluid,
2345-7,Glucose [Mass/volume] in Serum or Plasma,
1501-6,Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO,
1507-3,Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO,
20438-8,Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose,
10449-7,Glucose [Mass/volume] in Serum or Plasma --1 hour post meal,
12646-6,Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge,
1514-9,Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO,
1518-0,Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO,
20436-2,Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose,
1521-4,Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,
2350-7,Glucose [Mass/volume] in Urine,
5792-7,Glucose [Mass/volume] in Urine by Test strip,
2349-9,Glucose [Presence] in Urine,
25428-4,Glucose [Presence] in Urine by Test strip,
24353-5,Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma,
50608-9,Glucose tolerance 3 hours gestational panel - Serum or Plasma,
32546-4,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells,
2357-2,Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells,
2356-4,Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells,
13926-1,Glutamate decarboxylase 65 Ab [Units/volume] in Serum,
56540-8,Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay,
6125-9,Gluten IgE Ab [Units/volume] in Serum,
63091-3,Gluten IgG Ab [Mass/volume] in Serum,
6129-1,Goose feather IgE Ab [Units/volume] in Serum,
6156-4,Goosefoot IgE Ab [Units/volume] in Serum,
15284-3,Grey Alder IgE Ab [Units/volume] in Serum,
7110-0,Groundsel Tree IgE Ab [Units/volume] in Serum,
6113-5,Gum-Tree IgE Ab [Units/volume] in Serum,
29559-2,Haemophilus ducreyi DNA [Presence] in Specimen by NAA with probe detection,
11256-5,Haemophilus influenzae B IgG Ab [Mass/volume] in Serum,
4542-7,Haptoglobin [Mass/volume] in Serum or Plasma,
6136-6,Hazelnut IgE Ab [Units/volume] in Serum,
6137-4,Hazelnut Pollen IgE Ab [Units/volume] in Serum,
21687-9,HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
29588-1,Heavy metals panel - Blood,
29891-9,Helicobacter pylori [Presence] in Stomach by urea breath test,
22310-7,Helicobacter pylori Ab [Presence] in Serum,
7900-4,Helicobacter pylori Ab [Units/volume] in Serum,
31843-6,Helicobacter pylori Ag [Presence] in Stool,
17780-8,Helicobacter pylori Ag [Presence] in Stool by Immunoassay,
7901-2,Helicobacter pylori IgA Ab [Units/volume] in Serum,
6420-4,Helicobacter pylori IgA Ab [Units/volume] in Serum by Immunoassay,
16126-5,Helicobacter pylori IgG Ab [Presence] in Serum,
17859-0,Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay,
7902-0,Helicobacter pylori IgG Ab [Units/volume] in Serum,
5176-3,Helicobacter pylori IgG Ab [Units/volume] in Serum by Immunoassay,
5177-1,Helicobacter pylori IgM Ab [Units/volume] in Serum by Immunoassay,
20570-8,Hematocrit [Volume Fraction] of Blood,
11153-4,Hematocrit [Volume Fraction] of Body fluid,
718-7,Hemoglobin [Mass/volume] in Blood,
48035-0,Hemoglobin [Presence] in Cerebral spinal fluid,
17856-6,Hemoglobin A1c/Hemoglobin.total in Blood by HPLC,
24360-0,Hemoglobin and Hematocrit panel - Blood,
32140-6,Hemoglobin F [Presence] in Blood by Kleihauer-Betke method,
4621-9,Hemoglobin S [Presence] in Blood,
6864-3,Hemoglobin S [Presence] in Blood by Solubility test,
4625-0,Hemoglobin S/Hemoglobin.total in Blood,
2334-1,Hemoglobin.gastrointestinal [Presence] in Gastric fluid,
2335-8,Hemoglobin.gastrointestinal [Presence] in Stool,
29771-3,Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,
34701-3,Heparin induced platelet Ab [Presence] in Serum,
3274-8,Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic method,
24325-3,Hepatic function 2000 panel - Serum or Plasma,
13951-9,Hepatitis A virus Ab [Presence] in Serum by Immunoassay,
5183-9,Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay,
22314-9,Hepatitis A virus IgM Ab [Presence] in Serum,
13950-1,Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,
22315-6,Hepatitis A virus IgM Ab [Units/volume] in Serum,
5181-3,Hepatitis A virus IgM Ab [Units/volume] in Serum by Immunoassay,
16933-4,Hepatitis B virus core Ab [Presence] in Serum,
47440-3,Hepatitis B virus core Ab [Presence] in Serum from Donor,
13952-7,Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay,
5187-0,Hepatitis B virus core Ab [Units/volume] in Serum by Immunoassay,
31204-1,Hepatitis B virus core IgM Ab [Presence] in Serum,
24113-3,Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay,
5185-4,Hepatitis B virus core IgM Ab [Units/volume] in Serum or Plasma by Immunoassay,
29615-2,Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,
11258-1,Hepatitis B virus DNA [Units/volume] in Serum,
13953-5,Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay,
31844-4,Hepatitis B virus e Ag [Presence] in Serum,
13954-3,Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,
5191-2,Hepatitis B virus e Ag [Units/volume] in Serum by Immunoassay,
22322-2,Hepatitis B virus surface Ab [Presence] in Serum,
10900-9,Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,
16935-9,Hepatitis B virus surface Ab [Units/volume] in Serum,
5194-6,Hepatitis B virus surface Ab [Units/volume] in Serum by Radioimmunoassay (RIA),
5193-8,Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma by Immunoassay,
5195-3,Hepatitis B virus surface Ag [Presence] in Serum,
47364-5,Hepatitis B virus surface Ag [Presence] in Serum from Donor by Immunoassay,
5196-1,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay,
7905-3,Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test,
16128-1,Hepatitis C virus Ab [Presence] in Serum,
5199-5,Hepatitis C virus Ab [Presence] in Serum by Immunoblot,
47441-1,Hepatitis C virus Ab [Presence] in Serum from Donor,
13955-0,Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,
5198-7,Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay,
48159-8,Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay,
49846-9,Hepatitis C virus core Ag [Presence] in Blood or Marrow from Donor,
32286-7,Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection,
20416-4,Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,
47252-2,Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,
38180-6,Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection,
11259-9,Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection,
11011-4,Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,
22330-5,Hepatitis D virus Ab [Units/volume] in Serum,
17850-9,Herpes simplex virus 1 IgG Ab [Presence] in Serum,
51916-5,Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay,
5206-8,Herpes simplex virus 1 IgG Ab [Units/volume] in Serum by Immunoassay,
50758-2,Herpes simplex virus 1 IgM Ab [Titer] in Serum by Immunofluorescence,
20444-6,Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection,
49848-5,Herpes simplex virus 1+2 IgG Ab [Presence] in Serum by Immunoblot,
27948-9,Herpes simplex virus 1+2 IgG Ab [Units/volume] in Serum by Immunoassay,
41399-7,Herpes simplex virus 1+2 IgM Ab [Units/volume] in Serum by Immunoassay,
17851-7,Herpes simplex virus 2 IgG Ab [Presence] in Serum,
43180-9,Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay,
5209-2,Herpes simplex virus 2 IgG Ab [Units/volume] in Serum by Immunoassay,
26927-4,Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence,
5202-7,Herpes simplex virus Ab [Units/volume] in Serum by Immunoassay,
62454-4,Herpes simplex virus and Varicella zoster virus identified in Specimen by Organism specific culture,
5856-0,Herpes simplex virus identified in Genital specimen by Organism specific culture,
5859-4,Herpes simplex virus identified in Specimen by Organism specific culture,
35423-3,Herpes simplex virus identified in Vaginal fluid by Organism specific culture,
25435-9,Herpes simplex virus IgM Ab [Presence] in Serum,
40729-6,Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay,
5211-8,Herpes virus 6 IgG Ab [Units/volume] in Serum,
31418-7,Heterophile Ab [Presence] in Serum,
5213-4,Heterophile Ab [Presence] in Serum by Latex agglutination,
32632-2,HEXA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
21694-5,HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
34519-9,HFE gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,
21695-2,HFE gene.p.Cys282Tyr [Presence] in Blood or Tissue by Molecular genetics method,
29996-6,Histone IgG Ab [Units/volume] in Serum by Immunoassay,
5218-3,Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID),
19108-0,Histoplasma capsulatum Ag [Presence] in Serum,
44525-4,Histoplasma capsulatum Ag [Presence] in Serum by Immunoassay,
6428-7,Histoplasma capsulatum Ag [Units/volume] in Serum by Immunoassay,
19107-2,Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA),
44528-8,Histoplasma capsulatum M Ab [Presence] in Serum,
7917-8,HIV 1 Ab [Presence] in Serum,
29893-5,HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay,
5221-7,HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot,
24012-7,HIV 1 Ag [Presence] in Serum,
5222-5,HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay,
20447-9,HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,
25836-8,HIV 1 RNA [#/volume] (viral load) in Specimen by NAA with probe detection,
29539-4,HIV 1 RNA [Log #/volume] (viral load) in Plasma by Probe with signal amplification,
29541-0,HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,
25835-0,HIV 1 RNA [Presence] in Serum or Plasma by NAA with probe detection,
23876-6,HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe with signal amplification,
7918-6,HIV 1+2 Ab [Presence] in Serum,
44533-8,HIV 1+2 Ab [Presence] in Serum from Donor,
31201-7,HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay,
49580-4,HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay,
22357-8,HIV 1+2 Ab [Units/volume] in Serum,
48345-3,HIV 1+O+2 Ab [Presence] in Serum or Plasma,
48346-1,HIV 1+O+2 Ab [Units/volume] in Serum or Plasma,
5225-8,HIV 2 Ab [Presence] in Serum by Immunoblot,
30361-0,HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay,
49573-9,HIV genotype [Susceptibility] in Isolate by Genotype method Narrative,
33630-5,HIV protease gene mutations detected [Identifier],
46994-0,HLA-A+B+C (class I) Ab in Serum,
42358-2,HLA-B*57:01 [Presence] in Specimen,
4821-5,HLA-B27 [Presence],
26028-1,HLA-B27 [Presence] by Flow cytometry (FC),
26043-0,HLA-B27 [Presence] by NAA with probe detection,
2428-1,Homocysteine [Mass/volume] in Serum or Plasma,
13965-9,Homocysteine [Moles/volume] in Serum or Plasma,
38486-7,Homocystine [Presence] in DBS,
6844-5,Honey bee IgE Ab [Units/volume] in Serum,
6143-2,Horse dander IgE Ab [Units/volume] in Serum,
9828-5,House dust Greer IgE Ab [Units/volume] in Serum,
22070-7,HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
22362-8,HTLV I+II Ab [Presence] in Serum,
29901-6,HTLV I+II Ab [Presence] in Serum by Immunoassay,
16982-1,HTLV I+II Ab [Presence] in Serum by Immunoblot,
44538-7,HTLV I+II Ab [Presence] in Serum from Donor,
55180-4,Human epididymis protein 4 [Moles/volume] in Serum or Plasma,
71432-9,Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix,
30167-1,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification,
21440-3,Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe,
71431-1,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection,
21441-1,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe,
42481-2,Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification,
44547-8,Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification,
48560-7,Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection,
12308-3,HYDROcodone [Presence] in Urine,
9834-3,HYDROmorphone [Presence] in Urine,
2458-8,IgA [Mass/volume] in Serum or Plasma,
2460-4,IgD [Mass/volume] in Serum,
2462-0,IgE [Mass/volume] in Serum,
19113-0,IgE [Units/volume] in Serum or Plasma,
2464-6,IgG [Mass/volume] in Cerebral spinal fluid,
2465-3,IgG [Mass/volume] in Serum or Plasma,
47289-4,IgG and IgG subclass panel [Mass/volume] - Serum,
47290-2,IgG subclass panel [Mass/volume] - Serum,
2472-9,IgM [Mass/volume] in Serum or Plasma,
27831-7,Immune complex [Units/volume] in Serum or Plasma by C1q binding assay,
49120-9,Immunodeficiency follow-up panel - Specimen by Flow cytometry (FC),
45268-0,Immunodeficiency panel - Blood by Flow cytometry (FC),
49275-1,Immunofixation for Serum or Plasma Narrative,
13440-3,Immunofixation for Urine,
17793-1,Immunoglobulin light chains [Mass/volume] in 24 hour Urine,
43110-6,Immunoglobulin light chains panel - 24 hour Urine,
57778-3,Immunoglobulin light chains.free panel - Serum,
34550-4,Immunoglobulin panel [Mass/volume] - Serum,
1003-3,Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma,
5862-8,Influenza virus A Ag [Presence] in Specimen by Immunoassay,
5863-6,Influenza virus A Ag [Presence] in Specimen by Immunofluorescence,
72366-8,Influenza virus A and B Ag [Identifier] in Nose by Rapid immunoassay,
48509-4,Influenza virus A and B RNA [Identifier] in Specimen by NAA with probe detection,
31437-7,Influenza virus A IgG Ab [Units/volume] in Serum,
24015-0,Influenza virus A+B Ag [Presence] in Specimen,
6437-8,Influenza virus A+B Ag [Presence] in Specimen by Immunoassay,
6438-6,Influenza virus A+B Ag [Presence] in Specimen by Immunofluorescence,
46083-2,Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay,
5866-9,Influenza virus B Ag [Presence] in Specimen by Immunoassay,
17015-9,Influenza virus B IgG Ab [Units/volume] in Serum,
6604-3,Influenza virus identified in Specimen by Organism specific culture,
23883-2,Inhibin A [Mass/volume] in Serum or Plasma,
34319-4,Inhibin B [Mass/volume] in Serum or Plasma,
20448-7,Insulin [Units/volume] in Serum or Plasma,
8072-1,Insulin Ab [Units/volume] in Serum,
6901-3,Insulin Free [Units/volume] in Serum or Plasma,
48615-9,Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma,
2483-6,Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma,
2484-4,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma,
9537-2,Intrinsic factor blocking Ab [Presence] in Serum by Radioimmunoassay (RIA),
2494-3,Iodine [Mass/volume] in Serum or Plasma,
2498-4,Iron [Mass/volume] in Serum or Plasma,
50190-8,Iron and Iron binding capacity panel - Serum or Plasma,
2500-7,Iron binding capacity [Mass/volume] in Serum or Plasma,
2501-5,Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma,
31209-0,Islet cell 512 Ab [Units/volume] in Serum,
5669-7,Isopropanol [Mass/volume] in Serum or Plasma,
10853-0,Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified,
6151-5,Italian Cypress IgE Ab [Units/volume] in Serum,
43399-5,JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method,
5234-0,Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoassay,
11565-9,Jo-1 extractable nuclear Ab [Units/volume] in Serum,
6152-3,Johnson grass IgE Ab [Units/volume] in Serum,
11050-2,Kappa light chains [Mass/volume] in Serum or Plasma,
36916-5,Kappa light chains.free [Mass/volume] in Serum,
33773-3,Karyotype [Identifier] in Amniotic fluid Nominal,
29770-5,Karyotype [Identifier] in Blood or Tissue Nominal,
33893-9,Karyotype [Identifier] in Bone marrow Nominal,
6153-1,Kentucky blue grass IgE Ab [Units/volume] in Serum,
33058-9,Ketones [Mass/volume] in Serum or Plasma,
5797-6,Ketones [Mass/volume] in Urine by Test strip,
33903-6,Ketones [Presence] in Urine,
59297-2,Lacosamide [Mass/volume] in Serum or Plasma,
7445-0,Lactalbumin alpha IgE Ab [Units/volume] in Serum,
14118-4,Lactate [Mass/volume] in Serum or Plasma,
32693-4,Lactate [Moles/volume] in Blood,
2524-7,Lactate [Moles/volume] in Serum or Plasma,
14803-1,Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction,
60017-1,Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction,
14804-9,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,"LACTATO DESHIDROGENASA LDH , U/L"
14805-6,Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction,
42929-0,Lactate dehydrogenase panel - Serum or Plasma,
40703-1,Lactoferrin [Presence] in Stool by Immunoassay,
11051-0,Lambda light chains [Mass/volume] in Serum or Plasma,
33944-0,Lambda light chains.free [Mass/volume] in Serum or Plasma,
6948-4,lamoTRIgine [Mass/volume] in Serum or Plasma,
6158-0,Latex IgE Ab [Units/volume] in Serum,
5671-3,Lead [Mass/volume] in Blood,
10912-4,Lead [Mass/volume] in Serum or Plasma,
14976-5,Lecithin/Sphingomyelin [Ratio] in Amniotic fluid,
38901-5,Leflunomide [Mass/volume] in Serum or Plasma,
41499-5,Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay,
49914-5,Legionella pneumophila 1+2+3+4+5+6 IgM Ab [Presence] in Serum,
30046-7,Legionella pneumophila Ab [Units/volume] in Serum by Immunoassay,
588-4,Legionella pneumophila Ag [Presence] in Specimen by Immunofluorescence,
31870-9,Legionella pneumophila Ag [Presence] in Urine,
6447-7,Legionella pneumophila Ag [Presence] in Urine by Immunoassay,
6448-5,Legionella pneumophila Ag [Presence] in Urine by Radioimmunoassay (RIA),
593-4,Legionella sp identified in Specimen by Organism specific culture,
6239-8,Lenscale IgE Ab [Units/volume] in Serum,
21365-2,Leptin [Mass/volume] in Serum or Plasma,
7959-0,Leptospira sp Ab [Titer] in Serum,
15112-6,Leukocyte phosphatase [Units/volume] in Leukocytes,
26464-8,Leukocytes [#/volume] in Blood,
6690-2,Leukocytes [#/volume] in Blood by Automated count,
13349-6,Leukocytes [#/volume] in Stool by Manual count,
13655-6,Leukocytes [Presence] in Stool by Light microscopy,
30471-7,levETIRAcetam [Mass/volume] in Serum or Plasma,
3714-3,Lidocaine [Mass/volume] in Serum or Plasma,
15212-4,Lipase [Enzymatic activity/volume] in Body fluid,
3040-3,Lipase [Enzymatic activity/volume] in Serum or Plasma,
24331-1,Lipid 1996 panel - Serum or Plasma,
57698-3,Lipid panel with direct LDL - Serum or Plasma,
10835-7,Lipoprotein a [Mass/volume] in Serum or Plasma,
43583-4,Lipoprotein a [Moles/volume] in Serum or Plasma,
3719-2,Lithium [Mass/volume] in Serum or Plasma,
14334-7,Lithium [Moles/volume] in Serum or Plasma,
32220-6,Liver kidney microsomal 1 Ab [Units/volume] in Serum,
9838-4,Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence,
6165-5,Lobster IgE Ab [Units/volume] in Serum,
15191-0,Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma,
3284-7,Lupus anticoagulant neutralization platelet [Time] in Platelet poor plasma by Coagulation assay,
10501-5,Lutropin [Units/volume] in Serum or Plasma,
54227-4,Lymphoma - acute screen panel - Specimen by Flow cytometry (FC),
54228-2,Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC),
54229-0,Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC),
54226-6,Lymphoma panel - Specimen by Flow cytometry (FC),
29956-0,Lysozyme [Mass/volume] in Body fluid,
11183-1,Macadamia IgE Ab [Units/volume] in Serum,
24447-5,Magnesium [Mass/time] in 24 hour Urine,
26746-8,Magnesium [Mass/volume] in Red Blood Cells,
19123-9,Magnesium [Mass/volume] in Serum or Plasma,
19124-7,Magnesium [Mass/volume] in Urine,
2597-3,Magnesium [Moles/volume] in Red Blood Cells,
2601-3,Magnesium [Moles/volume] in Serum or Plasma,
7477-3,Mango Pollen IgE Ab [Units/volume] in Serum,
12232-5,Measles virus Ag [Presence] in Specimen by Immunofluorescence,
20479-2,Measles virus IgG Ab [Presence] in Serum,
35275-7,Measles virus IgG Ab [Presence] in Serum by Immunoassay,
5244-9,Measles virus IgG Ab [Units/volume] in Serum by Immunoassay,
2605-4,Meat fibers [Presence] in Stool by Light microscopy,
3746-5,Meperidine [Presence] in Urine,
5685-3,Mercury [Mass/volume] in Blood,
2609-6,Metanephrines [Mass/time] in 24 hour Urine,
3773-9,Methadone [Presence] in Urine,
19550-3,Methadone [Presence] in Urine by Screen method,
70149-0,Methadone [Presence] in Urine by Screen method >300 ng/mL,
5693-7,Methanol [Mass/volume] in Serum or Plasma,
3786-1,Methaqualone [Presence] in Urine,
2614-6,Methemoglobin/Hemoglobin.total in Blood,
35492-8,Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection,
13317-3,Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture,
14836-1,Methotrexate [Moles/volume] in Serum or Plasma,
13964-2,Methylmalonate [Moles/volume] in Serum or Plasma,
30003-8,Microalbumin [Mass/volume] in 24 hour Urine,
14957-5,Microalbumin [Mass/volume] in Urine,
58431-8,Microalbumin panel - 24 hour Urine,
58448-2,Microalbumin ug/min [Mass/time] in 24 hour Urine,
58447-4,Microalbumin/Creatinine panel in 24H Urine,
34535-5,Microalbumin/Creatinine panel in random Urine,
51714-4,Microscopic observation [Identifier] in Blood by Giemsa stain,
10355-6,Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain,
19765-7,Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain,
10524-7,Microscopic observation [Identifier] in Cervix by Cyto stain,
18500-9,Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep,
49050-8,Microscopic observation [Identifier] in Endocervical brush by Cyto stain,
11545-1,Microscopic observation [Identifier] in Specimen by Acid fast stain,
655-1,Microscopic observation [Identifier] in Specimen by Acid fast stain.Kinyoun modified,
10525-4,Microscopic observation [Identifier] in Specimen by Cyto stain,
664-3,Microscopic observation [Identifier] in Specimen by Gram stain,
666-8,Microscopic observation [Identifier] in Specimen by India ink prep,
667-6,Microscopic observation [Identifier] in Specimen by KOH preparation,
20431-3,Microscopic observation [Identifier] in Specimen by Smear,
680-9,Microscopic observation [Identifier] in Specimen by Wet preparation,
681-7,Microscopic observation [Identifier] in Specimen by Wright stain,
10526-2,Microscopic observation [Identifier] in Sputum by Cyto stain,
6473-3,Microscopic observation [Identifier] in Tissue by Trichrome stain,
11070-0,Microscopic observation [Identifier] in Urine by Cyto stain,
32819-5,Microsporidia identified in Stool by Trichrome stain,
6174-7,Milk IgE Ab [Units/volume] in Serum,
17284-1,Mitochondria Ab [Presence] in Serum by Immunofluorescence,
5247-2,Mitochondria Ab [Titer] in Serum by Immunofluorescence,
14251-3,Mitochondria M2 IgG Ab [Units/volume] in Serum,
16251-1,Morphine [Mass/volume] in Urine by Confirmatory method,
3830-7,Morphine [Presence] in Urine,
6178-8,Mountain Juniper IgE Ab [Units/volume] in Serum,
28005-7,MTHFR gene c.677C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal,
21709-1,MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
38415-6,MTHFR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,
6182-0,Mucor racemosus IgE Ab [Units/volume] in Serum,
6183-8,Mugwort IgE Ab [Units/volume] in Serum,
38476-8,Mullerian inhibiting substance [Mass/volume] in Serum or Plasma,
22415-4,Mumps virus IgG Ab [Presence] in Serum,
6476-6,Mumps virus IgG Ab [Presence] in Serum by Immunoassay,
7966-5,Mumps virus IgG Ab [Units/volume] in Serum,
25418-5,Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay,
25419-3,Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay,
533-0,Mycobacterium sp identified in Blood by Organism specific culture,
543-9,Mycobacterium sp identified in Specimen by Organism specific culture,
23905-3,Mycophenolate [Mass/volume] in Serum or Plasma,
42621-3,Mycoplasma hominis DNA [Presence] in Blood by NAA with probe detection,
29257-3,Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection,
5255-5,Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay,
58733-7,Mycoplasma pneumoniae IgG and IgM panel - Serum,
5256-3,Mycoplasma pneumoniae IgM Ab [Units/volume] in Serum by Immunoassay,
23301-5,Mycoplasma sp DNA [Presence] in Specimen by NAA with probe detection,
2638-5,Myelin basic protein [Mass/volume] in Cerebral spinal fluid,
6969-0,Myeloperoxidase Ab [Units/volume] in Serum,
46266-3,Myeloperoxidase Ab [Units/volume] in Serum by Immunoassay,
53833-0,Myoglobin [Mass/volume] in Blood,
2639-3,Myoglobin [Mass/volume] in Serum or Plasma,
2641-9,Myoglobin [Mass/volume] in Urine,
2640-1,Myoglobin [Presence] in Urine,
3834-9,N-acetylprocainamide [Mass/volume] in Serum or Plasma,
42637-9,Natriuretic peptide B [Mass/volume] in Blood,
30934-4,Natriuretic peptide B [Mass/volume] in Serum or Plasma,
33762-6,Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,
698-1,Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture,
47387-6,Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection,
24111-7,Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection,
21416-3,Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection,
50388-8,Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection,
32198-4,Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe,
43305-2,Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection,
5028-6,Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe,
53927-0,Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection,
60256-5,Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection,
6186-1,Nettle IgE Ab [Units/volume] in Serum,
41617-2,Neutrophil Ab [Presence] in Serum by Flow cytometry (FC),
21023-7,Neutrophil cytoplasmic Ab [Titer] in Serum,
48050-9,Neutrophils [Presence] in Stool by Wright stain,
54089-8,Newborn screening panel American Health Information Community (AHIC),
18244-4,Niacin [Mass/volume] in Serum or Plasma,
3854-7,Nicotine [Mass/volume] in Urine,
33716-2,Non-gynecological cytology study,
35622-0,Nordiazepam [Mass/volume] in Serum or Plasma by Screen method,
16228-9,Nordiazepam [Mass/volume] in Urine by Confirmatory method,
3861-2,Nordiazepam [Presence] in Urine,
3872-9,Nortriptyline [Mass/volume] in Serum or Plasma,
8061-4,Nuclear Ab [Presence] in Serum,
47383-5,Nuclear Ab [Presence] in Serum by Immunoassay,
29953-7,Nuclear Ab [Titer] in Serum,
5048-4,Nuclear Ab [Titer] in Serum by Immunofluorescence,
27200-5,Nuclear Ab [Units/volume] in Serum,
5047-6,Nuclear Ab [Units/volume] in Serum by Immunoassay,
63486-5,Nut allergen panel - Serum,
6190-3,Oat IgE Ab [Units/volume] in Serum,
24364-2,Obstetric 1996 panel - Serum and Blood,
56764-4,Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing,
8220-6,Opiates [Mass/volume] in Urine,
8214-9,Opiates [Presence] in Meconium,
8216-4,Opiates [Presence] in Meconium by Screen method,
3879-4,Opiates [Presence] in Urine,
18390-5,Opiates [Presence] in Urine by Confirmatory method,
19295-5,Opiates [Presence] in Urine by Screen method,
70151-6,Opiates [Presence] in Urine by Screen method >300 ng/mL,
6194-5,Orange IgE Ab [Units/volume] in Serum,
2692-2,Osmolality of Serum or Plasma,
2695-5,Osmolality of Urine,
2697-1,Osteocalcin [Mass/volume] in Serum or Plasma,
673-4,Ova and parasites identified in Specimen by Light microscopy,
10701-1,Ova and parasites identified in Stool by Concentration,
10704-5,Ova and parasites identified in Stool by Light microscopy,
2701-1,Oxalate [Mass/time] in 24 hour Urine,
2700-3,Oxalate [Mass/volume] in Urine,
14862-7,Oxalate [Moles/time] in 24 hour Urine,
16201-6,Oxazepam [Mass/volume] in Urine by Confirmatory method,
12361-2,Oxazepam [Presence] in Urine,
35331-8,OXcarbazepine [Mass/volume] in Serum or Plasma,
16249-5,oxyCODONE [Mass/volume] in Urine by Confirmatory method,
10998-3,oxyCODONE [Presence] in Urine,
19643-6,oxyCODONE [Presence] in Urine by Confirmatory method,
17395-5,oxyMORphone [Mass/volume] in Urine by Confirmatory method,
18325-1,oxyMORphone [Presence] in Urine by Confirmatory method,
7558-0,Oyster IgE Ab [Units/volume] in Serum,
56687-7,Pancreatic islet cell IgG Ab [Titer] in Serum by Immunofluorescence,
13327-2,Parainfluenza virus Ag [Presence] in Specimen by Immunofluorescence,
2729-2,Parathyrin related protein [Mass/volume] in Serum or Plasma,
2731-8,Parathyrin.intact [Mass/volume] in Serum or Plasma,
5271-2,Parietal cell Ab [Titer] in Serum by Immunofluorescence,
8087-9,Parietal cell Ab [Units/volume] in Serum,
55164-8,Paroxysmal nocturnal panel - Blood,
29675-6,Parvovirus B19 IgG Ab [Presence] in Serum,
29660-8,Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay,
25630-5,Parvovirus B19 IgG Ab [Titer] in Serum,
7983-0,Parvovirus B19 IgG Ab [Units/volume] in Serum,
5273-8,Parvovirus B19 IgG Ab [Units/volume] in Serum by Immunoassay,
7981-4,Parvovirus B19 IgM Ab [Presence] in Serum,
40658-7,Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay,
25631-3,Parvovirus B19 IgM Ab [Titer] in Serum,
7984-8,Parvovirus B19 IgM Ab [Units/volume] in Serum,
5274-6,Parvovirus B19 IgM Ab [Units/volume] in Serum by Immunoassay,
14869-2,Pathologist review of Blood tests,
6204-2,Pea IgE Ab [Units/volume] in Serum,
6206-7,Peanut IgE Ab [Units/volume] in Serum,
6208-3,Pecan or Hickory Nut IgE Ab [Units/volume] in Serum,
6209-1,Pecan or Hickory Tree IgE Ab [Units/volume] in Serum,
6851-0,Penicillin G IgE Ab [Units/volume] in Serum,
6212-5,Penicillium notatum IgE Ab [Units/volume] in Serum,
7369-2,Perennial rye grass IgE Ab [Units/volume] in Serum,
2748-2,pH of Body fluid,
2749-0,pH of Gastric fluid,
2755-7,pH of Stool,
2756-5,pH of Urine,
5803-2,pH of Urine by Test strip,
8234-7,Phencyclidine [Presence] in Meconium by Screen method,
3936-2,Phencyclidine [Presence] in Urine,
19659-2,Phencyclidine [Presence] in Urine by Screen method,
14310-7,Phencyclidine [Presence] in Urine by Screen method >25 ng/mL,
3948-7,PHENobarbital [Mass/volume] in Serum or Plasma,
29573-3,Phenylalanine [Moles/volume] in DBS,
14875-9,Phenylalanine [Moles/volume] in Serum or Plasma,
29571-7,Phenylalanine [Presence] in DBS,
3968-5,Phenytoin [Mass/volume] in Serum or Plasma,
3969-3,Phenytoin Free [Mass/volume] in Serum or Plasma,
2779-7,Phosphate [Mass/time] in 24 hour Urine,
2777-1,Phosphate [Mass/volume] in Serum or Plasma,
2778-9,Phosphate [Mass/volume] in Urine,
30165-5,Phosphatidylcholine/Albumin [Mass Ratio] in Amniotic fluid,
32031-7,Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay,
9326-0,Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay,
32032-5,Phosphatidylserine IgG Ab [Units/volume] in Serum by Immunoassay,
9327-8,Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay,
14246-3,Phosphatidylserine IgM Ab [Units/volume] in Serum,
32033-3,Phosphatidylserine IgM Ab [Units/volume] in Serum by Immunoassay,
9622-2,Phytonadione [Mass/volume] in Serum or Plasma,
6733-0,Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID),
10954-6,Pine Nut IgE Ab [Units/volume] in Serum,
7613-3,Pistachio IgE Ab [Units/volume] in Serum,
637-9,Plasmodium sp identified in Blood by Thick film,
33594-3,Platelet factor 4 [Presence] in Platelet poor plasma,
6002-0,Platelet factor 4 [Units/volume] in Platelet poor plasma,
72257-9,Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood,
26515-7,Platelets [#/volume] in Blood,
777-3,Platelets [#/volume] in Blood by Automated count,
700-5,Pneumocystis jiroveci Ag [Presence] in Specimen by Immunofluorescence,
5716-6,Polychlorinated biphenyl (PCB) [Mass/volume] in Serum or Plasma,
6219-0,Pork IgE Ab [Units/volume] in Serum,
6298-4,Potassium [Moles/volume] in Blood,
2823-3,Potassium [Moles/volume] in Serum or Plasma,
2828-2,Potassium [Moles/volume] in Urine,
6220-8,Potato IgE Ab [Units/volume] in Serum,
14338-8,Prealbumin [Mass/volume] in Serum or Plasma,
2837-3,Pregnenolone [Mass/volume] in Serum or Plasma,
7632-3,Privet IgE Ab [Units/volume] in Serum,
3982-6,Procainamide [Mass/volume] in Serum or Plasma,
2839-9,Progesterone [Mass/volume] in Serum or Plasma,
27882-0,Proinsulin [Moles/volume] in Serum or Plasma,
2842-3,Prolactin [Mass/volume] in Serum or Plasma,
20568-2,Prolactin [Mass/volume] in Serum or Plasma by Immunoassay,
3545-1,Propoxyphene [Mass/volume] in Urine,
19141-1,Propoxyphene [Presence] in Urine,
19429-0,Propoxyphene [Presence] in Urine by Screen method,
17494-6,Prostaglandin F2 alpha [Mass/volume] in Urine,
2857-1,Prostate specific Ag [Mass/volume] in Serum or Plasma,"ANTIGENO PROSTATICO ESPECIFICO, ng/mL"
35741-8,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL,
10886-0,Prostate Specific Ag Free [Mass/volume] in Serum or Plasma,"ANTIGENO PROSTATICO LIBRE, ng/mL"
19201-3,Prostate Specific Ag Free [Units/volume] in Serum or Plasma,
20420-6,Prostatic acid phosphatase [Mass/volume] in Serum,
2889-4,Protein [Mass/time] in 24 hour Urine,
21482-5,Protein [Mass/volume] in 24 hour Urine,
2881-1,Protein [Mass/volume] in Body fluid,
2880-3,Protein [Mass/volume] in Cerebral spinal fluid,
2885-2,Protein [Mass/volume] in Serum or Plasma,"PROTEINAS TOTALES, g/dL"
2888-6,Protein [Mass/volume] in Urine,
35663-4,Protein [Mass/volume] in Urine collected for unspecified duration,
6007-9,Protein C [Units/volume] in Platelet poor plasma by Coagulation assay,
27818-4,Protein C actual/normal in Platelet poor plasma by Chromogenic method,
27819-2,Protein C actual/normal in Platelet poor plasma by Coagulation assay,
6009-5,Protein C Ag [Units/volume] in Platelet poor plasma by Immunoassay,
27820-0,Protein C Ag actual/normal in Platelet poor plasma by Immunoassay,
24351-9,Protein electrophoresis panel - Serum or Plasma,
5892-5,Protein S [Units/volume] in Platelet poor plasma by Coagulation assay,
27822-6,Protein S actual/normal in Platelet poor plasma by Coagulation assay,
27823-4,Protein S Ag actual/normal in Platelet poor plasma by Immunoassay,
27821-8,Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay,
2890-2,Protein/Creatinine [Mass Ratio] in Urine,
6968-2,Proteinase 3 Ab [Units/volume] in Serum,
46267-1,Proteinase 3 Ab [Units/volume] in Serum by Immunoassay,
3289-6,Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay,
5902-2,Prothrombin time (PT),
2895-1,Protoporphyrin.zinc [Mass/volume] in Red Blood Cells,
29763-0,Protoporphyrin.zinc [Molar ratio] in Red Blood Cells,
34528-0,PT panel - Platelet poor plasma by Coagulation assay,
2900-9,Pyridoxine [Mass/volume] in Serum or Plasma,
14121-8,Pyruvate [Moles/volume] in Blood,
6222-4,Queen Palm IgE Ab [Units/volume] in Serum,
5290-2,Reagin Ab [Presence] in Cerebral spinal fluid by VDRL,
20507-0,Reagin Ab [Presence] in Serum by RPR,
5292-8,Reagin Ab [Presence] in Serum by VDRL,
22463-4,Reagin Ab [Presence] in Serum from Donor,
31147-2,Reagin Ab [Titer] in Serum by RPR,
32147-1,Reducing substances [Mass/volume] in Urine,
11060-1,Reducing substances [Presence] in Stool,
5809-9,Reducing substances [Presence] in Urine,
24362-6,Renal function 2000 panel - Serum or Plasma,
2915-7,Renin [Enzymatic activity/volume] in Plasma,
48841-1,"Respiratory allergen panel, US - Alaska a - Serum",
48932-8,"Respiratory allergen panel, US - Alaska b - Serum",
48835-3,"Respiratory allergen panel, US - Arid southwest - Serum",
48931-0,"Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum",
48837-9,"Respiratory allergen panel, US - California central valley - Serum",
48840-3,"Respiratory allergen panel, US - Cascade Pacific northwest a - Serum",
48929-4,"Respiratory allergen panel, US - Cascade Pacific northwest b - Serum",
48919-5,"Respiratory allergen panel, US - Central Florida - Serum",
48831-2,"Respiratory allergen panel, US - Central midwest a - Serum",
48925-2,"Respiratory allergen panel, US - Central midwest b - Serum",
49020-1,"Respiratory allergen panel, US - Coastal California - Serum",
48832-0,"Respiratory allergen panel, US - Great plains states a - Serum",
48926-0,"Respiratory allergen panel, US - Great plains states b - Serum",
48828-8,"Respiratory allergen panel, US - Greater Ohio valley a - Serum",
48923-7,"Respiratory allergen panel, US - Greater Ohio valley b - Serum",
49021-9,"Respiratory allergen panel, US - Greater Ohio valley c - Serum",
48933-6,"Respiratory allergen panel, US - Hawaii - Serum",
48839-5,"Respiratory allergen panel, US - Inland northwest a - Serum",
48928-6,"Respiratory allergen panel, US - Inland northwest b - Serum",
48838-7,"Respiratory allergen panel, US - Intermountain west a - Serum",
48930-2,"Respiratory allergen panel, US - Intermountain west b - Serum",
49018-5,"Respiratory allergen panel, US - Intermountain west c - Serum",
48825-4,"Respiratory allergen panel, US - Mid Atlantic states - Serum",
48918-7,"Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum",
48824-7,"Respiratory allergen panel, US - North Atlantic states a - Serum",
48916-1,"Respiratory allergen panel, US - North Atlantic states b - Serum",
49017-7,"Respiratory allergen panel, US - North Atlantic states c - Serum",
48830-4,"Respiratory allergen panel, US - Northern midwest states a - Serum",
48924-5,"Respiratory allergen panel, US - Northern midwest states b - Serum",
49022-7,"Respiratory allergen panel, US - Northern midwest states c - Serum",
49019-3,"Respiratory allergen panel, US - Puerto Rico - Serum",
48834-6,"Respiratory allergen panel, US - Rocky mountain states a - Serum",
48927-8,"Respiratory allergen panel, US - Rocky mountain states b - Serum",
48826-2,"Respiratory allergen panel, US - South Atlantic states a - Serum",
48917-9,"Respiratory allergen panel, US - South Atlantic states b - Serum",
48829-6,"Respiratory allergen panel, US - South central states - Serum",
48921-1,"Respiratory allergen panel, US - Southeast coast - Serum",
48836-1,"Respiratory allergen panel, US - Southern coastal California - Serum",
48920-3,"Respiratory allergen panel, US - Southern Florida - Serum",
48833-8,"Respiratory allergen panel, US - Southwestern grassland states - Serum",
48827-0,"Respiratory allergen panel, US - Subtropical Florida - Serum",
48922-9,"Respiratory allergen panel, US - West south central states - Serum",
5876-8,Respiratory syncytial virus Ag [Presence] in Specimen by Immunoassay,
5877-6,Respiratory syncytial virus Ag [Presence] in Specimen by Immunofluorescence,
9398-9,Reticulin Ab [Titer] in Serum,
4679-7,Reticulocytes/100 erythrocytes in Blood,
17849-1,Reticulocytes/100 erythrocytes in Blood by Automated count,
2923-1,Retinol [Mass/volume] in Serum or Plasma,
38496-6,Retinyl palmitate [Mass/volume] in Serum or Plasma,
10331-7,Rh [Type] in Blood,
1314-4,Rh immune globulin screen [interpretation],
17532-3,Rheumatoid arthritis nuclear Ab [Presence] in Serum,
33910-1,Rheumatoid factor [Presence] in Serum,
5297-7,Rheumatoid factor [Presence] in Serum by Latex agglutination,
15205-8,Rheumatoid factor [Units/volume] in Serum by Nephelometry,
11572-5,Rheumatoid factor [Units/volume] in Serum or Plasma,
6695-1,Riboflavin [Mass/volume] in Blood,
8091-1,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum,
5301-7,Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay,
29374-6,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,
51928-0,Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay,
6230-7,Rice IgE Ab [Units/volume] in Serum,
41476-3,Rickettsia rickettsii IgG Ab [Presence] in Serum by Immunoassay,
41475-5,Rickettsia rickettsii IgM Ab [Presence] in Serum by Immunoassay,
5880-0,Rotavirus Ag [Presence] in Stool by Immunoassay,
6232-3,Rough Marsh Elder IgE Ab [Units/volume] in Serum,
6233-1,Rough Pigweed IgE Ab [Units/volume] in Serum,
22496-4,Rubella virus Ab [Presence] in Serum,
5332-2,Rubella virus Ab [Presence] in Serum by Latex agglutination,
41763-4,Rubella virus IgG Ab [Titer] in Serum,
8014-3,Rubella virus IgG Ab [Units/volume] in Serum,
5334-8,Rubella virus IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,
8015-0,Rubella virus IgM Ab [Units/volume] in Serum,
5335-5,Rubella virus IgM Ab [Units/volume] in Serum by Immunoassay,
13177-1,Russian olive IgE Ab [Units/volume] in Serum,
22412-1,Saccharopolyspora rectivirgula Ab [Presence] in Serum,
4024-6,Salicylates [Mass/volume] in Serum or Plasma,
35597-4,Salicylates [Mass/volume] in Serum or Plasma by Screen method,
4023-8,Salicylates [Presence] in Serum or Plasma,
6237-2,Salmon IgE Ab [Units/volume] in Serum,
43371-4,Salmonella and Shigella sp identified in Stool by Organism specific culture,
6234-9,Saltwort IgE Ab [Units/volume] in Serum,
7691-9,Scallop IgE Ab [Units/volume] in Serum,
25757-6,Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay,
5348-8,SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoassay,
27416-7,SCL-70 extractable nuclear Ab [Units/volume] in Serum,
48800-7,Second trimester quad maternal screen panel - Serum or Plasma,
5724-0,Selenium [Mass/volume] in Serum or Plasma,
54231-6,Semen analysis fertility panel,
13361-1,Semen analysis panel,
50677-4,Semen analysis post vasectomy panel,
2939-7,Serotonin [Mass/volume] in Blood,
27057-9,Serotonin [Mass/volume] in Serum,
6242-2,Sesame Seed IgE Ab [Units/volume] in Serum,
6138-2,Setomelanomma rostrata IgE Ab [Units/volume] in Serum,
13967-5,Sex hormone binding globulin [Moles/volume] in Serum or Plasma,
6244-8,Sheep Sorrel IgE Ab [Units/volume] in Serum,
6246-3,Shrimp IgE Ab [Units/volume] in Serum,
15283-5,Silver Birch IgE Ab [Units/volume] in Serum,
29247-4,Sirolimus [Mass/volume] in Blood,
5352-0,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),
5351-2,Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoassay,
17792-3,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum,
33569-5,Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunoassay,
5354-6,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),
5353-8,Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoassay,
17791-5,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum,
45142-7,Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunoassay,
5357-9,Smith extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID),
5356-1,Smith extractable nuclear Ab [Presence] in Serum by Immunoassay,
11090-8,Smith extractable nuclear Ab [Units/volume] in Serum,
43182-5,Smith extractable nuclear Ab [Units/volume] in Serum by Immunoassay,
27048-8,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum,
21522-8,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum,
41053-0,SMN1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,
14252-1,Smooth muscle Ab [Presence] in Serum,
8095-2,Smooth muscle Ab [Titer] in Serum,
5358-7,Smooth muscle Ab [Titer] in Serum by Immunofluorescence,
2956-1,Sodium [Moles/time] in 24 hour Urine,
21525-1,Sodium [Moles/volume] in 24 hour Urine,
2947-0,Sodium [Moles/volume] in Blood,
2951-2,Sodium [Moles/volume] in Serum or Plasma,
2955-3,Sodium [Moles/volume] in Urine,
35678-2,Sodium [Moles/volume] in Urine collected for unspecified duration,
38420-6,Soluble liver IgG Ab [Units/volume] in Serum by Immunoassay,
2963-7,Somatotropin [Mass/volume] in Serum or Plasma,
6248-9,Soybean IgE Ab [Units/volume] in Serum,
2965-2,Specific gravity of Urine,
5811-5,Specific gravity of Urine by Test strip,
51623-7,Spermatozoa [#/volume] in Semen --post vasectomy,
6252-1,Stemphylium botryosum IgE Ab [Units/volume] in Serum,
6257-0,Strawberry IgE Ab [Units/volume] in Serum,
14207-5,Streptococcal DNAse B [Titer] in Serum,
582-7,Streptococcus agalactiae [Presence] in Genital specimen by Organism specific culture,
586-8,Streptococcus agalactiae [Presence] in Specimen by Organism specific culture,
585-0,Streptococcus agalactiae [Presence] in Throat by Organism specific culture,
584-3,Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture,
11266-4,Streptococcus agalactiae Ag [Presence] in Specimen,
6551-6,Streptococcus agalactiae Ag [Presence] in Throat by Immunofluorescence,
48683-7,Streptococcus agalactiae DNA [Presence] in Specimen by NAA with probe detection,
5034-4,Streptococcus agalactiae rRNA [Presence] in Specimen by Probe,
24027-5,Streptococcus pneumoniae Ag [Presence] in Urine,
11268-0,Streptococcus pyogenes [Presence] in Throat by Organism specific culture,
6559-9,Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence,
18481-2,Streptococcus pyogenes Ag [Presence] in Throat,
78012-2,Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay,
5036-9,Streptococcus pyogenes rRNA [Presence] in Specimen by Probe,
547-0,Streptococcus.beta-hemolytic [Presence] in Specimen by Organism specific culture,
546-2,Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture,
22568-0,Streptolysin O Ab [Titer] in Serum,
5370-2,Streptolysin O Ab [Units/volume] in Serum or Plasma,
34376-4,Strongyloides sp IgG Ab [Units/volume] in Serum by Immunoassay,
11529-5,Surgical pathology study,
11253-2,Tacrolimus [Mass/volume] in Blood,
32721-3,Tacrolimus [Mass/volume] in Serum or Plasma,
65758-5,T-cell helper (CD4) subset panel - Blood,
65759-3,T-cell subsets CD4 and CD8 panel - Blood,
21751-3,TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method,
2986-8,Testosterone [Mass/volume] in Serum or Plasma,
49041-7,Testosterone [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL,
2991-8,Testosterone Free [Mass/volume] in Serum or Plasma,
49042-5,Testosterone Free [Mass/volume] in Serum or Plasma by Detection limit <= 1.0 ng/dL,
25987-9,Testosterone Free [Moles/volume] in Serum or Plasma by Radioimmunoassay (RIA),
8169-5,Tetrahydrocannabinol [Presence] in Meconium by Screen method,
3426-4,Tetrahydrocannabinol [Presence] in Urine,
19415-9,Tetrahydrocannabinol [Presence] in Urine by Screen method,
4049-3,Theophylline [Mass/volume] in Serum or Plasma,
2998-3,Thiamine [Mass/volume] in Blood,
2999-1,Thiamine [Mass/volume] in Serum or Plasma,
32554-8,Thiamine [Moles/volume] in Blood,
20468-5,Thiamine [Moles/volume] in Serum or Plasma,
21563-2,Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells,
14182-0,Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunoassay,
3243-3,Thrombin time,
3013-0,Thyroglobulin [Mass/volume] in Serum or Plasma,
15210-8,Thyroglobulin Ab [Presence] in Serum,
5381-9,Thyroglobulin Ab [Titer] in Serum by Latex agglutination,
8098-6,Thyroglobulin Ab [Units/volume] in Serum or Plasma,
38505-4,Thyroglobulin recovery in Serum or Plasma,
30166-3,Thyroid stimulating immunoglobulins actual/normal in Serum,
32786-6,Thyroperoxidase Ab [Titer] in Serum or Plasma,
8099-4,Thyroperoxidase Ab [Units/volume] in Serum or Plasma,
29574-1,Thyrotropin [Presence] in DBS,
3016-3,Thyrotropin [Units/volume] in Serum or Plasma,
11580-8,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L,
11579-0,Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L,
57416-0,Thyrotropin receptor Ab [Units/volume] in Serum by Immunoassay,
31144-9,Thyroxine (T4) [Mass/volume] in DBS,
3026-2,Thyroxine (T4) [Mass/volume] in Serum or Plasma,
38506-2,Thyroxine (T4) [Presence] in DBS,
3024-7,Thyroxine (T4) free [Mass/volume] in Serum or Plasma,
6892-4,Thyroxine (T4) free [Mass/volume] in Serum or Plasma by Dialysis,
3021-3,Thyroxine binding globulin [Mass/volume] in Serum or Plasma,
6265-3,Timothy IgE Ab [Units/volume] in Serum,
35280-7,Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay,
31017-7,Tissue transglutaminase IgA Ab [Units/volume] in Serum,
46128-5,Tissue transglutaminase IgA Ab [Units/volume] in Serum by Immunoassay,
55727-2,Tissue transglutaminase IgA and IgG panel - Serum,
32998-7,Tissue transglutaminase IgG Ab [Units/volume] in Serum,
56537-4,Tissue transglutaminase IgG Ab [Units/volume] in Serum by Immunoassay,
35670-9,Tobramycin [Mass/volume] in Serum or Plasma,
4057-6,Tobramycin [Mass/volume] in Serum or Plasma --peak,
4059-2,Tobramycin [Mass/volume] in Serum or Plasma --trough,
6266-1,Tomato IgE Ab [Units/volume] in Serum,
17713-9,Topiramate [Mass/volume] in Serum or Plasma,
8039-0,Toxoplasma gondii IgG Ab [Units/volume] in Serum,
5388-4,Toxoplasma gondii IgG Ab [Units/volume] in Serum or Plasma by Immunoassay,
57770-0,Toxoplasma gondii IgG and IgM panel - Serum,
8040-8,Toxoplasma gondii IgM Ab [Units/volume] in Serum,
5390-0,Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay,
36922-3,TPMT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,
19710-3,traMADol [Presence] in Urine by Screen method,
3034-6,Transferrin [Mass/volume] in Serum or Plasma,
30248-9,Transferrin receptor.soluble [Mass/volume] in Serum or Plasma,
22587-0,Treponema pallidum Ab [Presence] in Serum,
24312-1,Treponema pallidum Ab [Presence] in Serum by Agglutination,
24110-9,Treponema pallidum Ab [Presence] in Serum by Immunoassay,
5393-4,Treponema pallidum Ab [Presence] in Serum by Immunofluorescence,
41163-7,Treponema pallidum DNA [Presence] in Specimen by NAA with probe detection,
6561-5,Treponema pallidum IgG Ab [Presence] in Serum,
47238-1,Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay,
17726-1,Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence,
10728-4,Trichomonas sp identified in Genital specimen by Organism specific culture,
6565-6,Trichomonas vaginalis [Presence] in Genital specimen by Wet preparation,
6568-0,Trichomonas vaginalis rRNA [Presence] in Genital specimen by Probe,
46154-1,Trichomonas vaginalis rRNA [Presence] in Specimen by NAA with probe detection,
4073-3,Tricyclic antidepressants [Presence] in Serum or Plasma,
11004-9,Tricyclic antidepressants [Presence] in Urine,
19312-8,Tricyclic antidepressants [Presence] in Urine by Screen method,
3043-7,Triglyceride [Mass/volume] in Blood,
2571-8,Triglyceride [Mass/volume] in Serum or Plasma,
3053-6,Triiodothyronine (T3) [Mass/volume] in Serum or Plasma,
3051-0,Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma,
3052-8,Triiodothyronine (T3).reverse [Mass/volume] in Serum or Plasma,
3054-4,Triiodothyronine (T3).true [Mass/volume] in Serum or Plasma,
3050-2,Triiodothyronine resin uptake (T3RU) in Serum or Plasma,
42757-5,Troponin I.cardiac [Mass/volume] in Blood,
10839-9,Troponin I.cardiac [Mass/volume] in Serum or Plasma,
49563-0,Troponin I.cardiac [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL,
6598-7,Troponin T.cardiac [Mass/volume] in Serum or Plasma,
21582-2,Tryptase [Mass/volume] in Serum or Plasma,
6270-3,Tuna IgE Ab [Units/volume] in Serum,
35571-9,Tyrosine [Moles/volume] in DBS,
20660-7,Tyrosine [Moles/volume] in Serum or Plasma,
3087-4,Urate [Mass/time] in 24 hour Urine,
3084-1,Urate [Mass/volume] in Serum or Plasma,UREA EN SUERO
3086-6,Urate [Mass/volume] in Urine,
3092-4,Urea [Mass/volume] in Urine,
22738-9,Urea [Moles/volume] in Specimen,
3096-5,Urea nitrogen [Mass/time] in 24 hour Urine,
6299-2,Urea nitrogen [Mass/volume] in Blood,
3093-2,Urea nitrogen [Mass/volume] in Body fluid,
3094-0,Urea nitrogen [Mass/volume] in Serum or Plasma,"NITROGENO UREICO EN SUERO, mg/dL"
11064-3,Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis,
11065-0,Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis,
3095-7,Urea nitrogen [Mass/volume] in Urine,
3097-3,Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma,
32637-1,Urease [Presence] in Tissue,
24356-8,Urinalysis complete panel - Urine,
58077-9,Urinalysis complete W Reflex Culture panel - Urine,
57020-0,Urinalysis dipstick W Reflex Microscopic panel - Urine,
24357-6,Urinalysis macro (dipstick) panel - Urine,
3107-0,Urobilinogen [Mass/volume] in Urine,
20405-7,Urobilinogen [Mass/volume] in Urine by Test strip,
19161-9,Urobilinogen [Units/volume] in Urine by Test strip,
4086-5,Valproate [Mass/volume] in Serum or Plasma,
20578-1,Vancomycin [Mass/volume] in Serum or Plasma,
4090-7,Vancomycin [Mass/volume] in Serum or Plasma --peak,
4092-3,Vancomycin [Mass/volume] in Serum or Plasma --trough,
9624-8,Vanillylmandelate [Mass/volume] in Urine,
43099-1,Vanillylmandelate and Creatinine panel - 24 hour Urine,
22600-1,Varicella zoster virus Ab [Presence] in Serum,
49451-8,Varicella zoster virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection,
19162-7,Varicella zoster virus IgG Ab [Presence] in Serum,
15410-4,Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay,
8047-3,Varicella zoster virus IgG Ab [Units/volume] in Serum,
5403-1,Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay,
5404-9,Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunoassay,
3125-2,Vasoactive intestinal peptide [Mass/volume] in Serum or Plasma,
3126-0,Vasopressin [Mass/volume] in Serum or Plasma,
6164-8,Virginia Live Oak IgE Ab [Units/volume] in Serum,
6584-7,Virus identified in Specimen by Culture,
3128-6,Viscosity of Serum,
35365-6,Vitamin D+Metabolites [Mass/volume] in Serum or Plasma,
6012-9,von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunoassay,
27816-8,von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay,
53622-7,von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic method,
32217-2,von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma,
6014-5,von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation,
38370-3,Voriconazole [Mass/volume] in Serum or Plasma,
6273-7,Walnut IgE Ab [Units/volume] in Serum,
32361-8,West Nile virus RNA [Presence] in Serum by NAA with probe detection,
6276-0,Wheat IgE Ab [Units/volume] in Serum,
6278-6,White Ash IgE Ab [Units/volume] in Serum,
41874-9,White Birch IgE Ab [Units/volume] in Serum,
6109-3,White Elm IgE Ab [Units/volume] in Serum,
13183-9,White Elm IgG Ab [Units/volume] in Serum,
7407-0,White Hickory IgE Ab [Units/volume] in Serum,
6281-0,White mulberry IgE Ab [Units/volume] in Serum,
6189-5,White Oak IgE Ab [Units/volume] in Serum,
7291-8,Whole Egg IgE Ab [Units/volume] in Serum,
6286-9,Wormwood IgE Ab [Units/volume] in Serum,
45042-9,XXX microorganism Ag [Identifier] in Specimen by Immunofluorescence,
35691-5,XXX microorganism DNA [Presence] in Specimen by NAA with probe detection,
18482-0,Yeast [Presence] in Specimen by Organism specific culture,
701-3,Yersinia sp identified in Specimen by Organism specific culture,
5763-8,Zinc [Mass/volume] in Serum or Plasma,
25557-0,Zinc [Moles/volume] in Red Blood Cells,
29620-2,Zonisamide [Mass/volume] in Serum or Plasma,
